4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Absence Seizure Disorder in 1 studies
4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bercovici, E | 1 |
| Cortez, MA | 1 |
| Snead, OC | 1 |
1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Absence Seizure Disorder
| Article | Year |
|---|---|
5-HT2 modulation of AY-9944 induced atypical absence seizures.
Topics: Amphetamines; Animals; Anticholesteremic Agents; Epilepsy, Absence; Ketanserin; Piperazines; Rats; R | 2007 |